{
    "url_original": "https://www.wsj.com/articles/mallinckrodt-bondholders-to-finance-bankruptcy-exit-after-market-snub-11653684109?mod=markets_major_pos14",
    "url": "mallinckrodt-bondholders-to-finance-bankruptcy-exit-after-market-snub-11653684109",
    "title": "Mallinckrodt Bondholders to Finance Bankruptcy Exit After Market Snub",
    "sub_head": "The drugmaker has had to downsize and revise its financing deal because of its struggles in securing investor support",
    "time": "2022-05-27 16:57:00",
    "body": "Drugmaker Mallinckrodt PLC has obtained support among unsecured bondholders to fund its exit from chapter 11 after a chilly reception from the leveraged credit market.<br />The Ireland-based company had been struggling to complete a financing deal needed to emerge from bankruptcy and has been working with Morgan Stanley to find investors. A $900 million loan deal failed to gain traction with market participants, partly due to concerns about investing in a company linked to opioid production amid growing market sensitivity about..."
}